Crossmark Global Holdings’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.1M | Sell |
|
|||||
|
2025
Q2 | $1.01M | Sell |
|
|||||
|
2025
Q1 | $972K | Buy |
|
|||||
|
2024
Q4 | $1.16M | Sell |
|
|||||
|
2024
Q3 | $978K | Buy |
|
|||||
|
2024
Q2 | $1M | Sell |
|
|||||
|
2024
Q1 | $1.09M | Sell |
|
|||||
|
2023
Q4 | $1.06M | Sell |
|
|||||
|
2023
Q3 | $977K | Sell |
|
|||||
|
2023
Q2 | $929K | Sell |
|
|||||
|
2023
Q1 | $953K | Buy |
|
|||||
|
2022
Q4 | $1.1M | Sell |
|
|||||
|
2022
Q3 | $986K | Sell |
|
|||||
|
2022
Q2 | $916K | Sell |
|
|||||
|
2022
Q1 | $890K | Sell |
|
|||||
|
2021
Q4 | $809K | Sell |
|
|||||
|
2021
Q3 | $1M | Sell |
|
|||||
|
2021
Q2 | $1.03M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $307K | Sell |
|
|||||
|
2018
Q2 | $267K | Sell |
|
|||||
|
2018
Q1 | $256K | Sell |
|
|||||
|
2017
Q4 | $322K | Sell |
|
|||||
|
2017
Q3 | $286K | Buy |
|
|||||
|
2016
Q3 | $286K | Buy |
|